AdaptHealth (AHCO) vs Cytek Biosciences (CTKB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cytek Biosciences (CTKB) has outperformed AdaptHealth (AHCO) over the past year, gaining 37.4% versus a loss of 32.3%. Over five years, AHCO leads with a -76.0% price change compared with -77.7% for CTKB. AdaptHealth is the larger company by market cap ($809.1 million vs $696.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AHCO | CTKB |
|---|---|---|
| Share price | $6.07 | $5.36 |
| Market cap | $809.13M | $696.71M |
| 1-day change | +3.15% | +0.37% |
| YTD return | -39.11% | +6.14% |
| 1-year return | -32.31% | +37.44% |
| 5-year return | -75.99% | -77.73% |
| Forward P/E | — | 76.57 |
| EPS (TTM) | $-1.82 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.43 | $6.21 |
| 52-week low | $5.21 | $3.31 |
| Distance from 52-week high | -54.84% | -13.69% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +46.08% | +3.73% |
| Average volume | 2.91M | 1.05M |
| Shares outstanding | 133.41M | 129.98M |
| Employees | 10,900 | 682 |
| Sector | Health Care | Industrials |
| Industry | Medical/Nursing Services | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CTKB has outperformed AHCO by 69.7 percentage points over the past year.
- The two companies sit in different sectors: AdaptHealth in Health Care and Cytek Biosciences in Industrials.
About AdaptHealth
AHCO stock →AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Health Care · Medical/Nursing Services · 10,900 employees
About Cytek Biosciences
CTKB stock →Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 682 employees
AHCO vs CTKB FAQ
Which is bigger, AdaptHealth or Cytek Biosciences?
AdaptHealth (AHCO) is larger, with a market capitalization of $809.13M compared with $696.71M for Cytek Biosciences (CTKB).
Which stock has performed better over the past year, AHCO or CTKB?
CTKB returned +37.44% over the past 12 months, compared with -32.31% for AHCO (price return, excluding dividends). Past performance does not predict future results.
Are AdaptHealth and Cytek Biosciences in the same industry?
No. AdaptHealth is in the Health Care sector, while Cytek Biosciences is in Industrials.